ORLANDO, FL—A new small but randomized controlled trial of PFO closure in cryptogenic stroke should help reassure that certain morphological features do indeed help pinpoint patients who would benefit ...

Abbott has launched its Amplatzer Tailsman PFO Occlosion System in Europe. The device is designed to treat people with a patent foramen ovale (PFO) who have had a stroke and are at risk of having ...

MINNEAPOLIS, Minnesota — The now publicly held AGA Medical has won Chinese approval for three of its devices and will begin selling there through its distributor, Abbott Laboratories. A broader ...

Abbott Laboratories ABT recently launched its Amplatzer Talisman PFO Occlusion System in Europe. The Talisman device aims to treat patent foramen ovale (PFO) patients who have had a stroke and are at ...

Abbott Laboratories ABT recently received FDA approval for its Amplatzer Talisman PFO Occlusion System to treat patent foramen ovale (PFO) patients at risk of recurrent ischemic stroke. The ...